Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1954 1
1955 2
1957 1
1959 1
1960 1
1961 1
1962 2
1963 2
1964 3
1967 2
1968 2
1970 1
1971 1
1973 4
1974 6
1975 1
1976 1
1977 5
1978 4
1979 4
1980 5
1981 11
1982 13
1983 19
1984 21
1985 27
1986 26
1987 46
1988 51
1989 36
1990 55
1991 70
1992 79
1993 84
1994 84
1995 102
1996 94
1997 126
1998 145
1999 129
2000 139
2001 194
2002 196
2003 241
2004 305
2005 351
2006 449
2007 496
2008 608
2009 659
2010 786
2011 898
2012 1063
2013 1234
2014 1416
2015 1575
2016 1777
2017 1814
2018 1973
2019 2240
2020 2681
2021 3070
2022 3642
2023 1663

Text availability

Article attribute

Article type

Publication date

Search Results

27,466 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion.
Jovin TG, Li C, Wu L, Wu C, Chen J, Jiang C, Shi Z, Gao Z, Song C, Chen W, Peng Y, Yao C, Wei M, Li T, Wei L, Xiao G, Yang H, Ren M, Duan J, Liu X, Yang Q, Liu Y, Zhu Q, Shi W, Zhu Q, Li X, Guo Z, Yang Q, Hou C, Zhao W, Ma Q, Zhang Y, Jiao L, Zhang H, Liebeskind DS, Liang H, Jadhav AP, Wen C, Brown S, Zhu L, Ye H, Ribo M, Chang M, Song H, Chen J, Ji X; BAOCHE Investigators. Jovin TG, et al. Among authors: wu l. N Engl J Med. 2022 Oct 13;387(15):1373-1384. doi: 10.1056/NEJMoa2207576. N Engl J Med. 2022. PMID: 36239645 Clinical Trial.
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study.
Zhong WZ, Wang Q, Mao WM, Xu ST, Wu L, Shen Y, Liu YY, Chen C, Cheng Y, Xu L, Wang J, Fei K, Li XF, Li J, Huang C, Liu ZD, Xu S, Chen KN, Xu SD, Liu LX, Yu P, Wang BH, Ma HT, Yan HH, Yang XN, Zhou Q, Wu YL; ADJUVANT investigators. Zhong WZ, et al. Among authors: wu l. Lancet Oncol. 2018 Jan;19(1):139-148. doi: 10.1016/S1470-2045(17)30729-5. Epub 2017 Nov 21. Lancet Oncol. 2018. PMID: 29174310 Clinical Trial.
Barriers to exocytotic vesicle discharge.
Zorec R, Wu LG. Zorec R, et al. Among authors: wu lg. Cell Calcium. 2023 Jun;112:102737. doi: 10.1016/j.ceca.2023.102737. Epub 2023 Apr 6. Cell Calcium. 2023. PMID: 37099857
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.
Bhatia V, Kamat NV, Pariva TE, Wu LT, Tsao A, Sasaki K, Sun H, Javier G, Nutt S, Coleman I, Hitchcock L, Zhang A, Rudoy D, Gulati R, Patel RA, Roudier MP, True LD, Srivastava S, Morrissey CM, Haffner MC, Nelson PS, Priceman SJ, Ishihara J, Lee JK. Bhatia V, et al. Among authors: wu lt. Nat Commun. 2023 Apr 11;14(1):2041. doi: 10.1038/s41467-023-37874-2. Nat Commun. 2023. PMID: 37041154 Free PMC article.
Contributions to the Flora of Tropical East Africa.
Du S, Wang M, Wei N, Mwachala G, Hu G, Wu L, Wang S, Wang Q. Du S, et al. Among authors: wu l. Plants (Basel). 2023 Mar 16;12(6):1336. doi: 10.3390/plants12061336. Plants (Basel). 2023. PMID: 36987024 Free PMC article. Review.
Predictors of relapse in Takayasu arteritis.
He S, Li R, Jin S, Wang Y, Li H, Duan X, Pan L, Wu L, Wang Y, Zhang Y, Wu Z, Li J, Yang Y, Tian X, Zeng X. He S, et al. Among authors: wu l. Eur J Intern Med. 2023 May;111:105-112. doi: 10.1016/j.ejim.2023.02.027. Epub 2023 Mar 12. Eur J Intern Med. 2023. PMID: 36914536 Free article.
27,466 results
You have reached the last available page of results. Please see the User Guide for more information.